arrow
C

Chiara Dentone

University of Genoa
H指数:30
被引数:2,917

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Antiviral Combination Treatment for COVID-19 in Immunocompromised Patients: Towards Defining Its Place in Therapy

免疫缺陷患者COVID-19的抗病毒联合治疗:定义其在治疗中的地位

2025-09-150
OAAI
Lower blood levels of isavuconazole in critically ill patients compared with other populations: possible need for therapeutic drug monitoring

与其他人群相比,重症患者的伊沙康康唑血液水平较低: 可能需要进行治疗药物监测

2024-02-154
PRE
External validation of unsupervised COVID-19 clinical phenotypes and their prognostic impact
2023-04-131
OAAI
Triple Combination Therapy With 2 Antivirals and Monoclonal Antibodies for Persistent or Relapsed Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Patients

三联疗法与2种抗病毒药物和单克隆抗体联合治疗免疫功能低下患者持续性或复发性新型冠状病毒感染

2023-03-2879
OA
Case report: Sotrovimab, remdesivir and nirmatrelvir/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19

病例报告: 在两名因新型冠状病毒肺炎住院的免疫功能低下的患者中,索特罗维单抗,雷姆西韦和尼马雷韦/利托那韦联合作为挽救治疗选择

2023-01-0925
OAAI
T2Bacteria and T2Resistance Assays in Critically Ill Patients with Sepsis or Septic Shock: A Descriptive Experience
2022-12-157
OA
Short Course of Antifungal Therapy in Patients With Uncomplicated Candida Bloodstream Infection: Another Case of Less Is More in the Clinical Setting?
2022-12-080
OAAI
Intermediate monocytes expansion and homing markers expression in COVID-19 patients associate with kidney dysfunction

新型冠状病毒肺炎患者的中间单核细胞扩增和归巢标记物表达与肾功能不全有关

2022-11-132
OAAI
High-temporal resolution profiling reveals distinct immune trajectories following the first and second doses of COVID-19 mRNA vaccines
2022-11-118
OAAI
Healthcare Worker Study Cohort to Determine the Level and Durability of Cellular and Humoral Immune Responses after Two Doses of SARS-CoV-2 Vaccination

医护人员研究队列,以确定两剂SARS-CoV-2疫苗接种后细胞和体液免疫反应的水平和持久性

2022-10-242
OAAI
Reactivation of Herpes Simplex Virus Type 1 (HSV-1) Detected on Bronchoalveolar Lavage Fluid (BALF) Samples in Critically Ill COVID-19 Patients Undergoing Invasive Mechanical Ventilation: Preliminary Results from Two Italian Centers
2022-02-0416
OAAI
Clinical presentation of secondary infectious complications in COVID-19 patients in intensive care unit treated with tocilizumab or standard of care
2021-12-019
OAAI
Early Administration of Bamlanivimab in Combination with Etesevimab Increases the Benefits of COVID-19 Treatment: Real-World Experience from the Liguria Region
2021-10-134
OAAI